ArticleFrontiers in microbiology2026
Precise mapping of two conserved minimal epitopes on the nucleocapsid protein of porcine epidemic diarrhea virus.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Porcine epidemic diarrhea virus (PEDV) is a highly contagious enteric pathogen that causes severe diarrhea and high mortality in neonatal piglets, leading to substantial economic losses in the swine industry. The nucleocapsid (N) protein is highly conserved and abundantly expressed during infection, making it a suitable target for serological detection. Methods: In this study, twomonoclonal antibodies (mAbs), C9 and G11, directed against the PEDV N protein were used to define minimal linear epitopes. A stepwise truncation approach based on overlapping recombinant fragments was applied to localize the antigenic regions. Results: The results showed that mAb C9 and mAb G11 recognized the minimal epitopes Discussion: These findings provide a more precise characterization of antigenic sites within the PEDVNprotein andmay be useful for the development of specific and reliable serological assays.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.